Activin-ActRII antagonists and uses for treating anemia

• 收藏
• 分享

专利权人:

Celgene Corporation;Acceleron Pharma Inc.

发明人:

Attie, Kenneth M.,Rovaldi, Christopher,Laadem, Abderrahmane

申请号：

AU2015358469

公开号：

AU2015358469A1

申请日:

2015.12.03

申请国别(地区):

AU

年份:

2017

代理人:

摘要：

Provided herein are methods for the treatment in a subject of anemia, anemia requiring RBC transfusion, low or intermediate- 1 -risk myelodysplastic syndromes (MDS), and/or non-proliferative chronic myelomonocytic leukemia (CMML) in any mammals wherein the methods comprise administration of Activin-ActRII signaling inhibitors to a subject in need of the treatment.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/